Navigation Links
PET Scans May Help Diagnose Movement Disorders
Date:1/12/2010

Can brain scans help diagnosis Parkinson’s disease at the onset of symptoms? One clever way to know for sure is to take snapshots of the brain at the time of the first symptoms of tremor or rigidity, and follow the patients over the years to see whether the diagnosis was correct. About 10 to 20 percent of patients initially thought to have Parkinson’s suffer from another movement disorder.

Manhasset, NY (Vocus) January 12, 2010 -- Can brain scans help diagnosis Parkinson’s disease at the onset of symptoms? One clever way to know for sure is to take snapshots of the brain at the time of the first symptoms of tremor or rigidity, and follow the patients over the years to see whether the diagnosis was correct. About 10 to 20 percent of patients initially thought to have Parkinson’s suffer from another movement disorder.

“This is a big problem for physicians,” said David Eidelberg, MD, head of the Center for Neurosciences at The Feinstein Institute for Medical Research in Manhasset, NY. “The treatments for Parkinson’s will not work for these patients and they can cause their own side effects.”

Dr. Eidelberg and his colleagues have used brain scans to identify the networks involved with three different neurological conditions – Parkinson’s, multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). They designed a study to follow 167 patients over three years to figure out whether the initial brain scan could be used to accurately predict the cause of the symptoms. This information is critical in making treatment decisions.

The researchers calculated the odds of having each of the three diseases based on the findings from fluoro-deoxy-glucose (FDG) positron emission tomography, a technology that images glucose metabolism. They found that FDG PET scan can identify what kind of movement disorder a patient has – something that now can only be assessed after years of clinical follow-up. “Accurate diagnosis is key,” said Dr. Eidelberg. Nine people died during the course of the study and an autopsy substantiated the imaging diagnosis.

“It is important to provide patients with an early diagnosis to ensure proper treatment,” said Dr. Eidelberg. “Also, if people are enrolled in clinical trials for Parkinson’s treatments, we want to know that we have enrolled the right patients.”

“The pathology is totally different but the earliest symptoms are so similar,” said Chris C. Tang, MD, the lead investigator of the study. Patients in the study were treated by movement disorder specialists, and after almost three years, the final diagnoses were matched with the initial findings on the brain scans. There was a 98 percent match suggesting that the scans could be used with great accuracy to diagnose correctly very early in the disease process.

The findings were published in the February edition of The Lancet Neurology. Dr. Eidelberg said that PET imaging can help clinicians more accurately diagnose Parkinson’s and other atypical movement disorders that share symptoms.

The researchers have mapped out distinct brain networks for each of the movement disorders. The studies suggest that MSA and PSP progress much faster than Parkinson’s. There are no effective treatments for MSA or PSP and using medicines for Parkinson’s disease can make things worse.

PET is an expensive tool and is not used routinely to help diagnosis Parkinson’s. They are expanding the study to include a larger number of patients.

About The Feinstein Institute for Medical Research
Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in cancer, leukemia, lymphoma, Parkinson's disease, Alzheimer’s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, inflammatory bowel disease, diabetes, human genetics, neuroimmunology, and medicinal chemistry. Feinstein researchers are developing new drugs and drug targets, and producing results where science meets the patient, annually enrolling some 10,000 subjects into clinical research programs.

###

Read the full story at http://www.prweb.com/releases/pet-scans/01/prweb3437554.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Combo PET-CT Scans Can Spot Hidden Cancers
2. Patient Factors Mar Accuracy of Multi-Detector CT Scans
3. Patients With Pacemakers Should Avoid MRI Scans
4. Studies Quantify Cancer Risks From CT Scans
5. Simple blood test could reduce repeat breast MRI scans in premenopausal women with irregular periods
6. Radiation From Medical Scans Soaring
7. CT Scans Surpass X-Rays for Swine Flu: Study
8. CT scans better than X-rays when detecting abnormalities in patients with H1N1 virus
9. Not All Kids With Head Injuries Need Brain Scans
10. Brain Scans Could Help Spot Schizophrenia Earlier
11. Scans Shed New Light on Concussions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PET Scans May Help Diagnose Movement Disorders 
(Date:4/25/2017)... ... April 25, 2017 , ... Coalition ... for Duchenne muscular dystrophy, and funding for Duchenne research, congratulates Capricor Therapeutics ... HOPE clinical trial in Duchenne announced today. , Coalition Duchenne funded studies ...
(Date:4/25/2017)... Boulder, CO (PRWEB) , ... April 25, 2017 ... ... Law and Liberty attempts to compare student test score performance for the 2015-16 ... one of the state’s voucher programs. Though it highlights important patterns in student ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who ... achieves results in a fraction of the time as traditional braces – Wilckodontics®. ... Dental Specialists, now offers this revolutionary treatment with or without a referral. ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers of America (BPC), ... reputable physician in their area, announces the launch of a new and proprietary customer ... are looking for reputable physicians to help them with back or neck pain and ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... of predictive analytics to its patient care management module. Using this new feature, ... a patient has been initiated on continuous positive airway pressure (CPAP), oral, or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
(Date:4/19/2017)... Calif. , April 19, 2017  SARES•REGIS ... buildings it is developing at Conejo Spectrum Business ... , to Atara Biotherapeutics, Inc. , a ... severe and life-threatening diseases that have been underserved ... allogeneic T-cell therapies for cancer, autoimmune and infectious ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: